NY-ESO-1 immunotherapy for ovarian cancer
26 Apr 2016
NY-ESO-1 immunotherapy for ovarian cancer
Imaging tumour habitats - life at the edge
WIN 2016: Preview of themes
WIN 2016: Preview of Speakers
Hypoxia and its impact on the immune system
Management of oral mucositis in cancer patients
Treating relapsed brain tumours with anti-angiogenic metronomic therapy
Editor's choice for January 2016
Utilising disease heterogeneity and emerging biomarkers to individualise prostate treatment
Impact of metformin on outcomes for metastatic renal cell carcinoma
Healthcare and QoL burden of symptomatic skeletal events in CRPC with bone mets
What does the iManageCancer project hope to achieve?